Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 43 of 43 entries
Sorted by: Best Match Show Resources per page
The E3 ligase malin plays a pivotal role in promoting nuclear glycogenolysis and histone acetylation.

Annals of translational medicine

Donohue KJ, Gentry MS, Sun RC.
PMID: 32309401
Ann Transl Med. 2020 Mar;8(5):254. doi: 10.21037/atm.2020.01.130.

No abstract available.

A novel deletion mutation in .

Neurology Asia

Orooj F, Umm-E-Kalsoom, Zhao X, Ahmad A, Ahmed IN, Faheem M, Hassan MJ, Minasian BA.
PMID: 34733372
Neurol Asia. 2021 Jun;26(2):427-433.

Lafora body disease (MIM-254780), a glycogen storage disease, characterized by Lafora bodies (deformed glycogen molecules) accumulating in multiple organs, is a rare form of myoclonic epilepsy. It manifests in early adolescent years, initially with seizures and myoclonus, followed by...

From Genetic Testing to Precision Medicine in Epilepsy.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Striano P, Minassian BA.
PMID: 31981099
Neurotherapeutics. 2020 Apr;17(2):609-615. doi: 10.1007/s13311-020-00835-4.

Epilepsy includes a number of medical conditions with recurrent seizures as common denominator. The large number of different syndromes and seizure types as well as the highly variable inter-individual response to the therapies makes management of this condition often...

Diabetes Mellitus in a Patient With Lafora Disease: Possible Links With Pancreatic β-Cell Dysfunction and Insulin Resistance.

Frontiers in pediatrics

Nicolescu RC, Al-Khawaga S, Minassian BA, Hussain K.
PMID: 30701169
Front Pediatr. 2019 Jan 16;6:424. doi: 10.3389/fped.2018.00424. eCollection 2018.

Lafora disease (LD) is a rare autosomal recessive disorder characterized by progressive myoclonic epilepsy followed by continuous neurological decline, culminating in death within 10 years. LD leads to accumulation of insoluble, abnormal, glycogen-like structures called Lafora bodies (LBs). It...

SGK1 (glucose transport), dishevelled2 (wnt signaling), LC3/p62 (autophagy) and p53 (apoptosis) proteins are unaltered in Lafora disease.

The all results journals. Biol

Wang P, Israelian L, Xue Y, Song S, Attisano L, Minassian BA.
PMID: 29152446
All Results J Biol. 2016;7(3):28-33.

Glycogen forms through the concerted actions of glycogen synthase (GS) which elongates glycogen strands, and glycogen branching enzyme (GBE). Lafora disease (LD) is a fatal neurodegenerative epilepsy that results from neuronal accumulation of hyperphosphorylated glycogen with excessively long strands...

Lack of Neuronal Glycogen Impairs Memory Formation and Learning-Dependent Synaptic Plasticity in Mice.

Frontiers in cellular neuroscience

Duran J, Gruart A, Varea O, López-Soldado I, Delgado-García JM, Guinovart JJ.
PMID: 31456667
Front Cell Neurosci. 2019 Aug 13;13:374. doi: 10.3389/fncel.2019.00374. eCollection 2019.

Since brain glycogen is stored mainly in astrocytes, the role of this polysaccharide in neurons has been largely overlooked. To study the existence and relevance of an active neuronal glycogen metabolism

Canine Lafora Disease: An Unstable Repeat Expansion Disorder.

Life (Basel, Switzerland)

von Klopmann T, Ahonen S, Espadas-Santiuste I, Matiasek K, Sanchez-Masian D, Rupp S, Vandenberghe H, Rose J, Wang T, Wang P, Minassian BA, Rusbridge C.
PMID: 34357061
Life (Basel). 2021 Jul 14;11(7). doi: 10.3390/life11070689.

Canine Lafora disease is a recessively inherited, rapidly progressing neurodegenerative disease caused by the accumulation of abnormally constructed insoluble glycogen Lafora bodies in the brain and other tissues due to the loss of NHL repeat containing E3 ubiquitin protein...

Showing 37 to 43 of 43 entries